Greenberg Traurig and Catenion are hosting the Maximizing Value from Strategic Partnering in Clinical Development Seminar on March 1st in Tokyo. The program will provide an in-depth look at the life cycle of an early stage biotech company that has developed an exciting new drug candidate and is evaluating its options for commercializing the product and obtaining the returns on its investment. Speakers will discuss the key issues that both the companies developing new drug products and those seeking new candidates for commercialization should consider when choosing partners and successfully partnering. GT's Koichiro Ohashi (Tokyo) will deliver the program's opening remarks and Catenion Founder and Senior Partner Christian Elze will lead a discussion on "Developing a value-maximising clinical development and partnering strategy" with contributions from GT's Wayne Elowe (ATL). Wayne will also speak with GT's David Dykeman (BOS) about "Identifying the right partner, negotiating a deal and implementing it" with contributions from Catenion's Christian Elze.
*This seminar is free of charge and an interpreter will be provided.